CBD Reversed Autism-Related Behavioral Problems in a Mouse Model

What the researchers found

In mice prenatally exposed to valproic acid (a model of autism), acute CBD at 30-60 mg/kg reversed pre-pulse inhibition deficits, decreased repetitive marble-burying, improved social interaction time, and restored object recognition memory. CBD at 60 mg/kg was effective across most tests but did not reduce stereotyped-like movements.

Why it matters

Autism spectrum disorder has limited treatment options, and many families report using CBD for their children. This preclinical study provides mechanistic support for CBD's potential to address multiple domains of autism-related behavior, particularly social deficits and cognitive impairment.

The numbers in context

CBD doses: 30 and 60 mg/kg. VPA dose: 500 mg/kg at embryonic day 12. Five behavioral tests. CBD reversed PPI deficits (both doses), reduced marble burying (60 mg/kg), improved social interaction (60 mg/kg), restored novel object recognition (both doses). Failed to reduce stereotyped movements.

How the study worked

Animal study using the valproic acid (VPA) autism model in mice. Adult mice (8 weeks old) exposed to VPA prenatally received acute CBD (30 or 60 mg/kg) and were tested across five behavioral paradigms: pre-pulse inhibition, marble burying, social interaction, activity, and novel object recognition.

What this study cannot tell us

Animal model using synthetic autism induction (VPA) may not capture the full complexity of human autism. Only acute, single-dose administration tested. Male mice only. Cannot determine long-term efficacy or safety. Doses used are high relative to typical human clinical doses.

How to read the evidence

Preliminary evidence from an animal model using acute dosing in a single sex.

When this study was published

2025 preclinical study using a well-established valproic acid autism model.

The bigger picture

This animal study complements the emerging clinical trial data on CBD for autism. The finding that CBD addresses multiple behavioral domains but not all (stereotyped movements were unaffected) suggests that CBD may be useful for some aspects of autism while other symptoms may require different interventions.

Questions still open

• Would chronic CBD administration produce sustained behavioral improvements? Does CBD work through the endocannabinoid system or other mechanisms in this model? Would lower doses be effective with repeated administration?

Common questions

Read the original research

Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.

Pharmacology, biochemistry, and behavior, 247, 173919

Citation

Pedrazzi, J F C; Sales, A J; Ponciano, R S M; Ferreira, L G; Ferreira, F R; Campos, A C; Hallak, J E C; Zuardi, A W; Del Bel, E A; Guimarães, F S; Crippa, J A. (2025). Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.. Pharmacology, biochemistry, and behavior, 247, 173919. https://doi.org/10.1016/j.pbb.2024.173919

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk